Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Angiotensin II antagonists described by Sankyo

June 28, 1996

Roberts' ProAmatine approaches FDA approval

June 21, 1996

ST-899 and ST-776 claimed by Sigma-Tau

June 21, 1996

Vesnarinone treatment recommendations

June 21, 1996

L-arginine is effective in heart failure patients

June 21, 1996

TFPI as tissue injury inhibitor

June 21, 1996

Pierre Fabre reveals cardiac cytoprotective agents

June 21, 1996

Generic version of indapamide approved in U.S.

June 21, 1996

Roussel Uclaf discloses endothelin antagonists

June 21, 1996

Endothelin antagonist claimed by Roche

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...